Global Pharmaceuticals & Biotech Large Cap High Growth Potential

Madrigal Pharmaceuticals

Market Cap: US$12.0b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Alnylam Pharmaceuticals

Market Cap: US$59.8b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Ascendis Pharma

Market Cap: US$12.2b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$106.1b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

ALTEOGEN

Market Cap: ₩29.4t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

argenx

Market Cap: €47.1b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Akeso

Market Cap: HK$111.9b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

WuXi XDC Cayman

Market Cap: HK$88.7b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Exelixis

Market Cap: US$11.7b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Tempus AI

Market Cap: US$12.6b

Operates as a healthcare technology company.

Innovent Biologics

Market Cap: HK$157.6b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

Insmed

Market Cap: US$40.7b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

BridgeBio Pharma

Market Cap: US$12.8b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

BeOne Medicines

Market Cap: US$41.8b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Eli Lilly

Market Cap: US$911.3b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Ionis Pharmaceuticals

Market Cap: US$11.8b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Torrent Pharmaceuticals

Market Cap: ₹1.3t

Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

Sandoz Group

Market Cap: CHF 23.6b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

Sartorius Stedim Biotech

Market Cap: €18.8b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

Galderma Group

Market Cap: CHF 35.7b

Operates as a dermatology company worldwide.

Exact Sciences

Market Cap: US$13.0b

Provides cancer screening and diagnostic test products in the United States and internationally.

Chugai Pharmaceutical

Market Cap: JP¥13.3t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

AbbVie

Market Cap: US$412.2b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Daiichi Sankyo Company

Market Cap: JP¥6.3t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Neurocrine Biosciences

Market Cap: US$14.6b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Mankind Pharma

Market Cap: ₹931.6b

Develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally.

Lonza Group

Market Cap: CHF 38.8b

Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

Celltrion

Market Cap: ₩43.0t

A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.

Swedish Orphan Biovitrum

Market Cap: SEK 117.0b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Novo Nordisk

Market Cap: DKK 1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.7b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Natera

Market Cap: US$28.9b

A diagnostics company, provides molecular testing services worldwide.

Royalty Pharma

Market Cap: US$22.9b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Medpace Holdings

Market Cap: US$16.8b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Viatris

Market Cap: US$12.7b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

AstraZeneca

Market Cap: UK£209.3b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.